Moreover, higher expression of myosin heavy chain (MyHC), a biomarker of cardiac hypertrophy, was observed in the STZ-induced group than in the A438079 treatment groups (Figures 2B,E). This evidence concerns the gene MYH6 and cardiac hypertrophy.